Evidence map›Paper›PMID 40328973›Full record

ReviewAnalytical and bioanalytical chemistry2025

Recent analytical advances in the detection and characterization of 3-O-sulfated heparan sulfate.

Elias Mernie, Joseph Zaia

Abstract readReview
In one paragraph

Review in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elias MernieDepartment of Biochemistry & Cell Biology, Center for Biomedical Mass Spectrometry, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, 02118, USA.
Joseph ZaiaDepartment of Biochemistry & Cell Biology, Center for Biomedical Mass Spectrometry, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, 02118, USA. jzaia@bu.edu.ORCID http://orcid.org/0000-0001-9497-8701

Funding

Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's DiseaseR01AG075876 · NIA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Thor Stein, JOSEPH ZAIA · 2022 to 2026
$3.9M
Methods for measuring matrisome molecule similarity during disease processesR35GM144090 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOSEPH ZAIA · 2022 to 2026
$2.1M
NIA NIH HHS R01 AG075876NIGMS NIH HHS R35 GM144090The National Institute of General Medical Sciences R35GM144090
6 · The paper itself

Abstract

Heparan sulfate (HS) is a linear, highly sulfated, and heterogeneous polysaccharide that covalently attaches to core proteins to form heparan sulfate proteoglycans (HSPGs). HSPGs are widely expressed in mammalian cells and are found on the cell surface and within the extracellular matrix (ECM). Structurally, HS consists of repeating disaccharide units composed of hexuronic acid (HexA) (either glucuronic acid (GlcA) or iduronic acid (IdoA)) linked to glucosamine (GlcN) units. The HS chain undergoes extensive post-polymerization modifications, including N-deacetylation of GlcN, C5-epimerization of HexA, and sulfation at various positions like 2-O-sulfation of HexA, as well as 3-O-, 6-O-, and N-sulfation of GlcN. Among these modifications, 3-O-sulfation of HS, produced by HS 3-O-sulfotransferase (HS3OST), is the rarest and most functionally significant. While 3-O-sulfated HS is well known for its anticoagulant properties through the activation of antithrombin, it also plays a critical role in various physiological and pathological processes, including cell differentiation, cancer progression, herpes simplex virus entry, and neuronal development. However, the precise mechanisms underlying these functions and their pathological implications remain inadequately characterized. This knowledge gap is primarily due to the low abundance of 3-O-sulfated HS and the lack of standardized analytical methods for its detection in biological samples. In this review, we summarize recent advancements in analytical techniques for the analysis of 3-O-sulfated HS and highlight potential future directions to improve its characterization and advance our understanding of its biological roles.

Indexed as

Heparan SulfateAnimalsHumansSulfotransferasesHeparan SulfateSulfotransferases3-O-SulfationHeparan sulfateMass spectrometryProteoglycans

Identifiers

PMID40328973
PMCPMC12595596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.